1.Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome.
Li Rong HONG ; Yu Jia CHEN ; Qing Lai JIANG ; Ru Lin JIA ; Chun LI ; Liang Hua FENG
Journal of Peking University(Health Sciences) 2023;55(6):1033-1038
OBJECTIVE:
To explore the predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome.
METHODS:
A total of 121 antiphospholipid syndrome (APS) patients who hospitalized at Peking University People's Hospital from March 2022 to January 2023 were selected and divided into thrombus group (50 cases) and nonthrombus group (71 cases) according to whether thrombosis occurred. The differences of laboratory characteristics including antiphospholipid antibodies were compared between the thrombotic and non-thrombotic groups. Chemiluminescent immunoassay was used to detect thrombomodulin (TM), thrombin-antithrombin complex (TAT), Plasmin-α2 plasmin inhibitor complex (PIC), and tissue plasminogen activator inhibitor complex (t-PAIC) in plasma from venous. The independent risk factors of thrombosis in patients with APS were determined using binary Logistic regression. Receiver operating characteristic (ROC) curve analysis was applied to evaluate the efficacy of each index on the prediction of thrombosis.
RESULTS:
Compared with the patients without thrombosis, the patients with thrombosis were older [49 (32, 64) years vs. 36 (32, 39) years, P < 0.05]. The percentages of male, smoking, hypertension, and global antiphospholipid syndrome score (GAPSS)≥10 in the patients with thrombosis were significantly higher than those in the patients without thrombosis (P < 0.05). The positive rates of anticardiolipin antibody (aCL) and lupus anticoagulant (LA) in the thrombotic group were significantly higher than those in the non-thrombotic group (P < 0.05), and the levels of prothrombin time, activated partial thromboplastin time, fibrinogen, fibrin degradation product in the thrombotic group were significantly higher than those in the non-thrombotic group (P < 0.05).Among the thrombosis group, venous thrombosis accounted for 19 (38.00%), including deep vein thrombosis (16, 84.21%) and pulmonary embolism accounted (5, 26.32%); Arterial thrombosis accounted for 35 (70.00%), including myocardial infarction (6, 17.14%) cerebral infarction (30, 85.71%). The patients in the thrombotic group had significantly greater TM levels than those in the non-thrombotic group (P < 0.05).There were no significant dif-ferences between the two groups in TAT (Z=-1.420, P=0.156), PIC (Z=-0.064, P=0.949), and t-PAIC (Z=-1.487, P=0.137). Univariate and binary Logistic regression analysis of relevant variables showed that advanced age [OR=1.126, P=0.002], elevated TM [OR=1.325, P=0.048], prolonged prothrombin time (PT) [OR=4.127, P=0.008] were independent risk factors for thrombosis in the patients with APS. ROC curve analysis of the above three independent risk factors showed that the combined detection of age, PT and TM had the highest Yoden index (0.727) and sensitivity (83.0%), with a specificity of 89.7%.
CONCLUSION
TAT, PIC, TM, and t-PAIC may reflect thrombus formation from the coagulation system, fibrinolysis system, and endothelial system. The combined of age TM and PT is superior to the application of a single marker, which has diagnostic value for the early identification of APS thrombosis.
Humans
;
Male
;
Antiphospholipid Syndrome/diagnosis*
;
Tissue Plasminogen Activator
;
Thrombosis/etiology*
;
Antibodies, Antiphospholipid/analysis*
;
Blood Coagulation Tests/adverse effects*
2.Retinal Vein Occlusion in Two Patients with Primary Antiphospholipid Syndrome.
Jin Kwan KIM ; Mi Young KIM ; Heung Sun YU ; Ho Kyoung JONG ; In Seog HWANG ; Choong Won LEE
The Korean Journal of Internal Medicine 2001;16(4):274-276
Primary antiphopholipid syndrome (APS) is a disease producing vascular thrombus with antiphospholipid antibody without association with autoimmune diseases as systemic lupus erythematosus. Retinal vein occlusion is a rare vascular manifestation in primary APS. We describe 2 cases of primary APS presenting with developing blurred vision. Each had central retinal vein occlusion and high titer of IgG anticardiolipin antibody.
Adult
;
Antibodies, Anticardiolipin/analysis
;
Antiphospholipid Syndrome/*complications/immunology
;
Case Report
;
Human
;
Male
;
Middle Age
;
Retinal Vein Occlusion/*etiology/immunology
3.Indeterminate lupus anticoagulant results: Prevalence and clinical significance.
Khaldoun ALKAYED ; Kandice KOTTKE-MARCHANT
Korean Journal of Hematology 2011;46(4):239-243
BACKGROUND: Reports of indeterminate lupus anticoagulant (LAC) results are common; however, no published data on their prevalence or clinical significance are available. We investigated the prevalence and clinical characteristics of patients with indeterminate LAC. METHODS: We retrospectively reviewed the clinical and serologic characteristics of 256 unselected patients with LAC results. RESULTS: Indeterminate results were observed in 32.7% of LAC profiles that were least frequent (25.4%) when activated partial thromboplastin time (aPTT) was normal, most frequent (39.8%) when aPTT was elevated, and were observed in 35% of patients taking warfarin. The final indeterminate LAC cohort included 65 patients with a mean follow-up of 18 months. Malignancy and autoimmune disease were present in 29% and 25% of patients, respectively. The most common thrombotic events were deep vein thrombosis (DVT) (28%), cerebral ischemic stroke (14%) and pulmonary embolism (14%). Patients with indeterminate results were more likely to be men, older, and with a history of DVT, superficial thrombosis, or myocardial infarction than patients with negative tests (N=106). Concurrent warfarin therapy was more prevalent in the indeterminate group, but was not statistically significant. In the multivariate analysis, none of the variables showed statistical significance. During follow-up, 10 of 16 patients with indeterminate results showed change in classification upon retesting. CONCLUSION: Patients with indeterminate LAC results were common, and their clinical characteristics differed from those with negative results. There is a need for a prospective study of the clinical history of patients with indeterminate LAC results.
Antibodies, Antiphospholipid
;
Antiphospholipid Syndrome
;
Autoimmune Diseases
;
Cohort Studies
;
Follow-Up Studies
;
Humans
;
Lupus Coagulation Inhibitor
;
Male
;
Multivariate Analysis
;
Myocardial Infarction
;
Partial Thromboplastin Time
;
Prevalence
;
Pulmonary Embolism
;
Retrospective Studies
;
Stroke
;
Thrombosis
;
Venous Thrombosis
;
Warfarin
4.Usefulness of Silica Clotting Time for Detection of Lupus Anticoagulants.
Hye Ryun LEE ; Ji Eun KIM ; Soo Hyun HA ; Hyun Kyung KIM ; Seonyang PARK ; Han Ik CHO
The Korean Journal of Laboratory Medicine 2009;29(6):497-504
BACKGROUND: The presence of lupus anticoagulants (LA) is a strong risk factor for thrombosis in antiphospholipid syndrome. We investigated the usefulness of addition of silica clotting time (SCT) to the pre-existing dilute Russell's viper venom test (dRVVT) for detection of LA. Also, we analyzed differences in the thrombotic features and the characteristics of antiphospholipid antibodies between dRVVT and SCT. METHODS: A total of 167 patients positive for LA or anti-cardiolipin (anti-CL) antibody and 76 healthy controls were enrolled. The dRVVT and SCT were used for detection of LA. Anti-CL, anti-beta2-glycoprotein I (anti-beta2 GPI) and anti-prothrombin (anti-PT) antibodies were measured using commercial ELISA kits. RESULTS: In detection of thrombosis, the sensitivity of the combined test of SCT and dRVVT was 56.4%, which was higher than that of dRVVT alone (46.2%) or SCT alone (23.1%). The specificity of the combined test (80.9%) was comparable to that of dRVVT (81.9%). Also, odds ratio for predicting thrombosis was higher in the combined test than in dRVVT or SCT alone. When normalized LA ratio of the two tests was compared, the group of patients with higher ratio of SCT showed significantly higher prevalence of recurrent abortion and higher positivity of IgG types of anti-CL, anti-beta2 GPI and anti-PT than the group with higher ratio of dRVVT. CONCLUSIONS: Addition of SCT to dRVVT can improve the detection sensitivity of thrombosis in LA test. And the high normalized LA ratio of SCT may be a useful parameter for detection of recurrent abortion.
Adult
;
Aged
;
Antibodies, Anticardiolipin/analysis
;
Antibodies, Antiphospholipid/analysis
;
Blood Coagulation Tests/*methods
;
Female
;
Humans
;
Immunoglobulin G/analysis
;
Immunoglobulin M/analysis
;
Lupus Coagulation Inhibitor/*blood
;
Male
;
Middle Aged
;
Prothrombin/immunology
;
Prothrombin Time/methods
;
Reagent Kits, Diagnostic
;
Sensitivity and Specificity
;
Silicon Dioxide/*chemistry
;
Thrombosis/diagnosis
;
beta 2-Glycoprotein I/immunology
5.Fetal outcome and clinical feature during pregnancy in systemic lupus erythematosus.
Jung Hyun SHIN ; Eun Young LEE ; Chang Keun LEE ; You Sook CHO ; Ahm KIM ; Bin YOO ; Hee Bom MOON
Korean Journal of Medicine 2003;65(5):511-519
BACKGROUN: Our aim was to assess the rate of flare in patients with systemic lupus erythematosus (SLE) during pregnancy, to describe fetal outcomes in lupus in Asan Medical Center and to identify clinical or serological factors that would predict pregnancy loss and poor fetal outcome. METHODS: We retrospectively studied 49 pregnancies in 47 women with SLE. Clinical and laboratory data were identified from medical record. RESULTS: Lupus flare occurred in 30 (61.2%) of the pregnancies, mostly in the second trimester. Flares presented most commonly as involvement of skin or joints, constitutional symptoms. All of the patients with flare were treated with glucocorticosteroid. There was no predictive factor for flare of lupus during pregnancy. There were 37 (75.5%) live births and 12 (24.5%) fetal losses. Of live births, 10 (20.4%) were premature babies, 5 (10.2%) intrauterine growth retardation. Of fetal losses, 5 (10.2%) were spontaneous abortion, 5 (10.2%) therapeutic abortion, 2 (4.1%) still births. Using univariate analysis, predictive factors for adverse fetal outcome include antiphospholipid antibody, renal involvement, active lupus at conception and flare of lupus during pregnancy. Using multivariate analysis, antiphospholipid antibody was the only significant predictor for fetal loss, and lupus flare during pregnancy was the only significant predictor for poor fetal outcome. CONCLUSION: There was no predictive factor for the flare of lupus during pregnancy. Most lupus pregnancies did well, but there was a higher rate of adverse fetal outcome. Antiphospholipid antibody and flare of lupus during pregnancy were the only important predictors of fetal loss and premature birth, respectively.
Abortion, Spontaneous
;
Abortion, Therapeutic
;
Antibodies, Antiphospholipid
;
Chungcheongnam-do
;
Female
;
Fertilization
;
Fetal Growth Retardation
;
Humans
;
Joints
;
Live Birth
;
Lupus Erythematosus, Systemic*
;
Medical Records
;
Multivariate Analysis
;
Parturition
;
Pregnancy Outcome
;
Pregnancy Trimester, Second
;
Pregnancy*
;
Premature Birth
;
Retrospective Studies
;
Skin